Gelonghui May 16 | Jin Dawei (002626.SZ) held a performance briefing on May 16, 2024 to discuss “What technical reserves does the company have in the field of synthetic biology?” The company replied that the company has strong technical reserves and accumulation in the field of synthetic biological product manufacturing, and that the company has mastered the five core technologies of synthetic biological green manufacturing, microbial fermentation, chemical synthesis, natural product extraction, and microcapsule technology. The company has established a large-scale biological enzyme bank platform with in vitro biosynthesis and in vivo biosynthesis research and development capabilities. The company has formed a complete technological leadership in industrial strain creation, intelligent control of fermentation processes, and product application development, and has built a fermentation production process centered on a microbial cell factory. A number of new raw material products have already entered the preparation stage for industrial production, and many new raw material products are in the small trial and pilot stages.